CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed
Drug / intervention
Niacin extended release and simvastatin tabletsdrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00082251
NCT00082251Phase 3Completed
CompareCT.gov

Safety & Efficacy of a Combination Niacin ER/Simvastatin in Patients With Dyslipidemia: A Dose-Ranging Study - SEACOAST

Kos Pharmaceuticals·interventional·Posted May 5, 2004·Updated Nov 1, 2006

In Brief

A Phase 3 clinical trial evaluating Niacin extended release and simvastatin tablets for Hypercholesterolemia. Completed.

Detailed Summary

The purpose of this study is to compare the effectiveness and safety of different doses of Niacin ER/Simvastatin (NS), in subjects with elevated fat levels in their blood (dyslipidemia).

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHypercholesterolemia
Countries--
Collaborators--

Timeline

Phase 3CompletedFinished
200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedMay 5, 2004
TodayJul 2, 2026
Posted 22.2 years ago

Interventions

Niacin extended release and simvastatin tabletsdrug